Obi Greenman
Fortune : 15 M $ au 30/06/2026
Fortune : 15 M $ au 30/06/2026
William Mariner Greenman is Executive Chairman at Cerus Corp.
since 2026.
Former roles include Independent Director at Aduro BioTech, Inc., Independent Director at Chinook Therapeutics, Inc. from 2010 to 2023, and Senior Vice President-Biotech Division at Baxter International, Inc. in 1995.
Education includes undergraduate studies at Stanford University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CERUS CORPORATION 2,52 % | 30/06/2026 | 5 053 036 ( 2,52 % ) | 15 M $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CERUS CORPORATION | Président | 16/03/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Directeur/Membre du Conseil | 11/08/2023 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/01/1995 |
| CHINOOK THERAPEUTICS, INC. | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Baxter International, Inc.
Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Cerus Corp.
Cerus Corp. Medical SpecialtiesHealth Technology Develops and commercializes the INTERCEPT Blood System for platelets and plasma | Health Technology |
Aduro BioTech, Inc.
Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company, which focuses on the development of technology platforms for cancer | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chinook Therapeutics, Inc.
Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes medicines for kidney diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national